Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 93,095	$ 241,619
Prepaid expenses	203,750	177,569
Other current assets	16,922	29,651
Total Current Assets	313,767	448,839
Restricted cash		3,500
Total Assets	313,767	452,339
Current Liabilities:
Accounts payable	223,041	193,095
Accrued expenses	1,097,021	1,159,950
Accrued expenses - related parties	72,000	198,701
Accrued interest	532,960	515,910
Accrued interest - related parties	649,265	481,334
Accrued compensation	766,102	724,185
Notes payable	759,912	1,013,000
Notes payable - related parties	150,000	150,000
Convertible notes payable, net of debt discount of $71,124 and $82,403 as of December 31, 2021 and 2020, respectively	1,834,446	1,493,153
Convertible notes payable - related parties, net of debt discount of $0 and $75,317 as of December 31, 2021 and 2020, respectively	3,725,000	2,149,683
Advances payable	135,000	195,500
Advances payable - related party	100,000	100,000
Financing liability	27,926
Accrued dividend payable	67,229	25,210
Total Liabilities	10,139,902	8,399,721
Commitments and contingencies (Note 11)
Stockholders’ Deficiency:
Common Stock, $0.001 par value, 200,000,000 shares authorized; 34,360,546 and 32,538,411 shares issued and outstanding as of December 31, 2021 and 2020, respectively	34,361	32,538
Additional paid-in capital	21,316,318	17,724,731
Accumulated deficit	(31,178,428)	(25,705,993)
Total Stockholders’ Deficiency	(9,826,135)	(7,947,382)
Total Liabilities and Stockholders’ Deficiency	313,767	452,339
Series A Convertible Preferred Stock [Member]
Stockholders’ Deficiency:
Preferred stock, value	1,342	1,342
Series C Convertible Preferred Stock [Member]
Stockholders’ Deficiency:
Preferred stock, value	$ 272